Cardiogen Sciences
Palo Alto, US · Founded 2014
Healthtech
Founders & leadership
EM
Edmund M. RuffinNamed on SEC filing
LG
Louis G. LangeNamed on SEC filing
SG
Silvia Giuliana PrioriNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$525.8K disclosed across 1 round · 2014
▶$525.8KraisedDec 2014 · 9 investors · Other Health CareRule 506(b)
▶$525.8KraisedDec 2014 · 9 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Edmund M. RuffinDirector
- Louis G. LangeExecutive Officer, Director
- Silvia Giuliana PrioriDirector
- Offering amount
- $525.8K
- Amount sold
- $525.8K
- Proceeds to insiders
- $60.8K
- First sale
- Nov 2014
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Cardiogen Sciences raised?
- Cardiogen Sciences has disclosed $525.8K raised across 1 round.
- Where is Cardiogen Sciences headquartered?
- Cardiogen Sciences is headquartered in Palo Alto, US.